Perspective
Our work in Perspective
-
Accelerating Alzheimer’s Disease Drug Innovations from the Research Pipeline to Patients
Goldman, Fillit, and Neumann outline policy options that would lead to more innovation.
Categorized in -
NAFTA Talks’ Potential Diabetes Threat
U.S. proposals to restrict junk food warnings will adversely affect the health of citizens in 3 countries writes Goldman and Gonzalez Gonzales in U.S. News
Categorized in -
Walmart and CVS Have 15,000 Combined Stores. Why are Both Trying to Buy Health Insurance Companies?
Trish and Goldman write these vertical megadeals will certainly disrupt care patterns and lower costs, but no one can know whether the savings will flow to shareholder or patients in the LA Times.
Categorized in -
Is the National Health Protection Scheme Good Public Policy?
India recently announced an ambitious plan called the National Health Protection Scheme (NHPS) to provide government-sponsored insurance to roughly 500 million people or nearly 40% of India’s population.
Categorized in -
Congress Should Replace Medicare’s Merit-Based Incentive Payment System
Editor’s note: This piece was originally published at Health Affairs Blog on February 26, 2018. In 2015, Congress passed the Medicare Access and CHIP Reauthorization Act (MACRA) on a strong bipartisan vote. In addition to repealing the Sustainable Growth Rate formula that was used to set the level of physician payment rates, MACRA changed the […]
Categorized in -
Prescription Drug Coupons: A One-Size-Fits-All Policy Approach Doesn’t Fit The Evidence
Schaeffer Center researchers discuss the complicated landscape of prescription drug copay coupons.
Categorized in -
Here’s How We Can Increase the Supply of Organs and Keep People off of the Waiting List
Jena and Goldman propose a new approach that recognizes a simple fact: Many diseases can affect the same organ in The Hill.
Categorized in -
This Is What’s at Stake if U.S. Drug Prices Fall — and Europeans Don’t Pay More
If pharmaceutical revenue increases, more money will go into R&D and new treatments
Categorized in -
How to Interpret the Cadillac Tax Rate: A Technical Note
The Affordable Care Act’s excise tax on employer-sponsored plans, commonly referred to as the “Cadillac tax,” imposes a 40 percent excise tax on employer-provided health benefits with a cost in excess of specified thresholds.
Categorized in -
LiveMint: How Inequality Works
Inequality is not the same thing as unfairness; and, it is the latter that has incited so much political turmoil in the rich world today, says Angus Deaton
Categorized in
You must be logged in to post a comment.